Curcumin
Also sold as: Turmeric, Turmeric & Curcumin
Best-in-class: Meriva 500-SF
The active polyphenol of turmeric, in Thorne's phytosome (Meriva) delivery that dramatically improves its otherwise poor absorption.
Curcumin quick facts
| Suggested dose | 500–1,000 mg of a bioavailable form (Meriva) daily with food. |
| How often | daily |
| Who it's for | Joint/inflammation support, recovery, and metabolic health. |
| Best-in-class brand | Meriva 500-SF |
Judge the delivery system, not the milligrams. A high-dose plain turmeric capsule can easily deliver less curcumin to your blood than a properly formulated low-dose one, and the trials that worked used enhanced forms. The strongest evidence is for osteoarthritis, where it performs respectably against anti-inflammatories in head-to-head trials. Take it with fat. Piperine raises curcumin levels by blocking a clearance pathway several medications also use, so that's a real interaction route. It also has mild antiplatelet activity and can worsen reflux.
How Curcumin actually works
Curcumin's main anti-inflammatory action is inhibition of NF-κB, the transcription factor that switches on most inflammatory gene programs — so it acts upstream of many mediators at once rather than blocking a single enzyme. The problem is delivery, and it's severe: plain curcumin is poorly soluble, poorly absorbed, and rapidly conjugated by the liver, so ordinary turmeric produces almost undetectable blood levels. Every credible product solves this — phytosome complexes bind it to phospholipid, and piperine from black pepper inhibits the glucuronidation that clears it.
Where to get Curcumin
Buy Meriva 500-SF at Thorne →What it is, why it recurs, and where this fits — free to read.
The evidence for Curcumin
Graded by what exists behind each claim.
✅ Clinically validated
- Meta-analyses show reduced pain/inflammation in osteoarthritis, sometimes comparable to NSAIDs with better tolerability.
- Lowers CRP and other inflammatory markers in RCTs.
- Signals for improved metabolic and mood markers in smaller trials.
📊 Correlative data
- Higher turmeric-consuming populations show lower inflammatory-disease rates (confounded by overall diet).
🧪 Theoretical / extrapolated benefits
- Broad anti-cancer and longevity mechanisms (NF-κB, Nrf2) are well-characterized in vitro but not proven as human outcomes.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Curcumin actually does
Curcumin's problem is not that it has no mechanism. It is that it has too many, and the reason is chemical. The molecule carries two phenolic hydroxyls, two Michael acceptor sites in the alpha,beta-unsaturated diketone, and a metal-chelating beta-diketone that exists mostly as the enol. Michael acceptors react covalently with cysteine thiols on whatever protein they meet. That is why curcumin inhibits dozens of unrelated enzymes in vitro and why medicinal chemists classify it among the pan-assay interference compounds: reactivity is not the same as selectivity.
The mechanisms with the best support are two transcription factors pointing opposite ways. Curcumin inhibits IKK-beta and prevents nuclear factor kappa B translocation, which reduces transcription of tumor necrosis factor, interleukin-6, cyclooxygenase-2 and inducible nitric oxide synthase. It also modifies cysteines on KEAP1, releasing NRF2 to transcribe the phase II antioxidant battery. One arm turns inflammation down, the other turns endogenous defense up.
A large share of what it does may never be systemic at all. Because so little is absorbed, luminal concentrations in the colon are orders of magnitude higher than plasma concentrations. The two randomized trials with the hardest endpoints in this literature are both in ulcerative colitis Hanai 2006 Lang 2015, which is a disease of the tissue the unabsorbed fraction is sitting on.
What reaches plasma is mostly not curcumin. Absorbed curcumin is glucuronidated and sulfated in the enterocyte and the hepatocyte within minutes; circulating curcumin glucuronide typically exceeds free curcumin by an order of magnitude or more. Whether the conjugates are active, inert, or a reservoir that is deconjugated at target tissue is the unresolved question underneath every bioavailability claim.
And there is a reduced metabolite nobody talks about. Curcumin is reduced by alcohol dehydrogenase and NADPH-dependent reductases to tetrahydrocurcumin, which has no Michael acceptor, is more stable, and is a better antioxidant. If tetrahydrocurcumin is the real actor, then formulations that raise parent curcumin are optimizing the wrong molecule.
Cell, rodent, human — and where it stops
The unusual thing about curcumin is that the surrogate the industry competes on is a pharmacokinetic one, and it has never been connected to an outcome.
In cells, curcumin does almost everything, which is the warning. Micromolar concentrations inhibit dozens of targets. Plasma concentrations after a gram of unformulated curcumin are in the low nanomolar range. That gap of three orders of magnitude is the central translation problem and no formulation closes it.
The human evidence with real endpoints is in the bowel. Curcumin as maintenance therapy in quiescent ulcerative colitis reduced relapse in a randomized, multicenter, double-blind, placebo-controlled trial Hanai 2006, and curcumin added to mesalamine induced remission in mild-to-moderate disease in a second randomized trial Lang 2015. Remission and relapse are clinical endpoints, not markers, and those two trials are the strongest thing on this page.
In joints the endpoint is a symptom scale and the effect is real but modest. A systematic review and meta-analysis of turmeric extracts and curcumin for arthritis symptoms found consistent improvement in pain and function scores across small trials Daily 2016. Pain scales in osteoarthritis carry large placebo responses, which the review itself notes as a limitation.
The bioavailability surrogate is where the money is. A lecithin-formulated curcuminoid delivered substantially greater absorption than the unformulated standardized mixture in a comparative human study Cuomo 2011, and every premium product in this category makes a version of that claim. Not one of them has been randomized against unformulated curcumin with a clinical endpoint.
The obstacle to transfer is therefore inverted. The trials with outcomes used cheap unformulated curcumin at grams per day; the products with the best pharmacokinetics have the least outcome evidence. Buying the formulation on the strength of the trial is buying a different exposure to the one that was tested Portincasa 2016.
Curcumin — which form, and does it matter
'Curcumin' on a label usually means curcuminoids, and that is three molecules. Standardized turmeric extract is typically 95 percent curcuminoids, of which roughly 77 percent is curcumin, 17 percent demethoxycurcumin and 3 percent bisdemethoxycurcumin. Those differ in stability and in activity. Turmeric powder as a spice is only about 2 to 5 percent curcuminoids, so a teaspoon and a capsule are two orders of magnitude apart.
The absorption obstacles are four and formulations attack different ones. Aqueous solubility is negligible; degradation at intestinal pH is rapid; enterocyte glucuronidation is fast; and biliary excretion clears what survives. Phospholipid complexes attack solubility and membrane transit Cuomo 2011; piperine attacks glucuronidation by inhibiting UDP-glucuronosyltransferase; nanoparticle and cyclodextrin systems attack solubility; gamma-cyclodextrin and micellar systems attack both.
The pharmacokinetic numbers explain the dosing. Oral bioavailability of unformulated curcumin is under 1 percent. Peak plasma concentration arrives at roughly 1 to 2 hours and the plasma half-life is short, on the order of 1 to 2 hours for the parent compound. Extensive first-pass metabolism by UDP-glucuronosyltransferase and sulfotransferase in gut wall and liver is the dominant route, with biliary rather than renal clearance carrying most of the dose. Twice-daily dosing follows from that clock.
Piperine is a form decision with a real interaction attached. Black pepper extract raises curcumin exposure substantially by inhibiting glucuronidation, and the same inhibition applies to any co-administered drug cleared that way. A curcumin product containing piperine is a drug-interaction product, and the label rarely says so.
What no formulation resolves. If the active species is a conjugate or the reduced metabolite rather than free curcumin, then the plasma curcumin number every product competes on is not the number that matters. That question has never been settled, which means the entire premium category rests on an assumption Cuomo 2011.
What would have to be true, and how you would know it was not
1. Predict a formulation raises plasma curcumin and predict that is where the demonstration stops. On a phospholipid or micellar product, predict measurably higher plasma curcuminoids than an equal dose of standardized extract Cuomo 2011, and predict no published trial in which that difference produced a better clinical result.
2. In inflammatory bowel disease, predict the endpoint the trials used. Predict a reduced relapse rate over 6 months on 2 g a day of unformulated curcumin as maintenance alongside standard therapy Hanai 2006, with fecal calprotectin and hs-CRP as the objective read-outs. This is the one indication where the prediction is positive and the evidence is a clinical endpoint.
3. The prediction that cuts against the product. In a healthy adult taking curcumin for general inflammation, predict no change in hs-CRP at 12 weeks, because baseline hs-CRP in a healthy person is already low and there is no inflammation to suppress. A trial in healthy adults showing a durable hs-CRP reduction would falsify this page.
4. In osteoarthritis, predict a symptom improvement and predict you will not be able to attribute it. Predict pain and function scores improve over 8 to 12 weeks Daily 2016, and predict a trial with an active comparator and an objective measure — walking speed, timed stair climb — shows a much smaller difference. That gap is the placebo response, and it is the falsifiable part.
5. Predict an iron effect if the dose is high and long. Curcumin chelates iron and has been reported to induce a functional iron deficiency in animals at high intake. Predict ferritin drifts down over 6 months of gram doses in somebody with marginal iron status, and check a ferritin and an iron panel rather than assuming a spice cannot do that.
What nobody has tested yet
The formulation-versus-outcome trial has never been run. Randomizing a high-bioavailability curcumin against unformulated curcumin at the dose used in the colitis trials, with relapse as the endpoint, would tell the field whether the pharmacokinetic surrogate means anything Cuomo 2011 Hanai 2006. It is a straightforward trial and nobody has done it.
Nobody knows which species is active. Free curcumin, the glucuronide, the sulfate and tetrahydrocurcumin all circulate, and no study has established which one accounts for a clinical effect. Until that is settled, optimizing plasma curcumin is optimizing on faith.
The colitis result has not been extended. Two randomized trials in ulcerative colitis is a stronger base than most botanicals have and is still small Hanai 2006 Lang 2015. A multicenter trial with endoscopic and histologic endpoints would either establish curcumin as a genuine adjunct or close the question.
And the combination products are unstudied as combinations. Curcumin is routinely sold with boswellia, ginger, fennel or piperine; one randomized trial tested a curcumin and fennel essential oil combination in irritable bowel syndrome and reported symptom and quality of life improvement Portincasa 2016, without a factorial design that could attribute the effect. That is the general state of the category.
Curcumin — its own safety story, not its category's
Gastrointestinal effects dominate and they are dose-related. Nausea, diarrhea, reflux and abdominal discomfort at gram doses, and yellow stool, which is harmless and startling. Tolerability was acceptable in the colitis trials at 2 to 3 g a day Hanai 2006.
Hepatotoxicity is the signal that changed the risk profile of this category. Cases of acute liver injury associated with high-absorption curcumin products have been reported, clustering around formulations designed to raise exposure and, in several series, around a susceptibility genotype. That is a specific consequence of the bioavailability arms race rather than a property of turmeric as a spice.
Iron is the interaction with the clearest mechanism. Curcumin binds iron and can reduce its absorption, which matters for anyone with marginal iron status, heavy menstrual losses or an existing anemia.
The drug interactions run through conjugation, and piperine makes them worse. Curcumin inhibits several cytochrome P450 isoenzymes and UDP-glucuronosyltransferases in vitro, and piperine-containing products add a well-documented glucuronidation inhibitor. Anticoagulants and antiplatelet drugs deserve particular attention, because curcumin has antiplatelet activity of its own.
Who should be careful. Anyone with gallstones or bile duct obstruction, because curcumin stimulates gallbladder contraction. Anyone on an anticoagulant. Anyone scheduled for surgery, where stopping two weeks beforehand is the conventional handling. And pregnancy, where doses above culinary amounts have no safety data. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.
Sources read for this page
- Cuomo J, Appendino G, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products 2011 · PMID 21413691
- Hanai H. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006 · PMID 17101300
- Lang A. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol 2015 · PMID 25724700
- Daily JW, et al. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal of Medicinal Food, 2016 · PMID 27533649
- Portincasa P, Bonfrate L, Scribano ML, et al. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. Journal of Gastrointestinal and Liver Diseases 2016 · PMID 27308645
How you would know if it worked
These are the markers that recommend this product on their own pages, so they are the ones that should move if it is doing what it is sold for.
- hs-CRP (High-Sensitivity C-Reactive Protein) — Omega-3 (EPA/DHA) 2–4 g/day, curcumin (bioavailable form) 500–1000 mg, vitamin D if deficient Retest: 3 months after intervention; repeat any high value.
- ESR (Sed Rate) — Omega-3s, curcumin, vitamin D if deficient Retest: 3 months after intervention.
- TNF-Alpha — Omega-3s (EPA/DHA 2–4 g), curcumin, vitamin D Retest: 3 months after intervention.
- Rheumatoid Factor — Omega-3s (2–4 g EPA/DHA has trial evidence for RA joint symptoms), curcumin, vitamin D Retest: Per rheumatologist.
- TGF Beta-1 — Omega-3s, curcumin Retest: Per physician.
The cheapest panel carrying hs-CRP (High-Sensitivity C-Reactive Protein) and at least one other of these is Frequent Illness & Immune Resilience, at $108 — the panel is named for a different question, and the marker is the same marker. That is the whole cost of finding out.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Curcumin — safety & side effects
- GI upset, nausea and diarrhea, mostly at higher doses.
- Rare idiosyncratic liver injury has been reported. It is not dose-dependent and not predictable, so the practical rule is to stop and get liver enzymes checked if you develop unexplained fatigue, nausea, dark urine or yellowing of the eyes. Turmeric and curcumin have accumulated a real number of case reports, particularly with high-absorption formulations and in people carrying a specific HLA type. Piperine-enhanced products are over-represented.
- Antiplatelet activity — Additive bleeding risk with anticoagulants and antiplatelets — warfarin, apixaban, rivaroxaban, clopidogrel, and aspirin at any dose. The interaction is pharmacodynamic rather than metabolic, so it does not show up as a changed drug level; it shows up as bruising, nosebleeds or a raised INR. Stop at least two weeks before any surgery or dental extraction. Surgeons ask about prescription blood thinners and rarely about supplements, so this one is on you to volunteer.
- Inhibits CYP3A4 and P-gp, so it raises levels of a range of medications. Lowers blood sugar. Avoid with gallstones or bile duct obstruction — it stimulates gallbladder contraction. Some turmeric powders are adulterated with lead chromate.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Build your foundation with Coach Cam
The full Supplement Vault — 371 products across 14 categories with clinical, correlative & theoretical evidence, plus my Thorne partner links — lives inside Skool alongside 278 peptides.
Join Skool — $10/mo →Bloodwork to run alongside Curcumin
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation claim, measured |
| Comprehensive Metabolic Panel (CMP) | Liver. High-absorption formulations have case reports of injury |
The Inflammation Deep Dive panel covers these in one order — 10 markers, $248.35 with the discount applied.
Check results you already have → · All 103 markers A–Z
Curcumin — frequently asked questions
What is Curcumin?
The active polyphenol of turmeric, in Thorne's phytosome (Meriva) delivery that dramatically improves its otherwise poor absorption.
What is the suggested dose of Curcumin?
500–1,000 mg of a bioavailable form (Meriva) daily with food. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
What are the researched benefits of Curcumin?
Meta-analyses show reduced pain/inflammation in osteoarthritis, sometimes comparable to NSAIDs with better tolerability.
Who is Curcumin for?
Joint/inflammation support, recovery, and metabolic health.
Where can I buy Curcumin?
Coach Cam sources Curcumin from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
Curcumin inside a finished plan
One arm of 3 Protocol Blueprints, free to read in full.
What Curcumin is used for
Curcumin appears under 8 goals in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
Curcumin is the inflammation-resolution arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.